Correspondence 0001829126-23-005901 from SSHT S&T Group Ltd. (SSHT)
SSHT S&T Group Ltd.
Date: Sept. 5, 2023 · CIK: 0001975222 · Accession: 0001829126-23-005901
AI Filing Summary & Sentiment
File numbers found in text: 333-271831
Referenced dates: August 1, 2023
Show Raw Text
CORRESP
1
filename1.htm
SSHT
S&T Group Ltd.
46
Reeves Road, Pakuranga
Auckland,
New Zealand, 2010
September 5,
2023
Attorneys
Robert Shapiro and Linda Cvrkel
Division
of Corporation Finance
Securities
and Exchange Commission
Re: SSHT
S&T Group Ltd.
Registration
Statement on Form S-1/A
File
No. 333-271831
Filed
July 6, 2023
Dear
Mr. Shapiro and Ms. Cvrkel:
In
response to your letter dated August 1, 2023, the following information is hereby submitted on behalf of SSHT S&T Group Ltd.
(the “Company”). Amendment No. 2 to the Registration Statement on Form S-1 is being filed in conjunction with this correspondence.
For your convenience, we have reproduced the Staff’s comments below in italicized text immediately before our response.
Amendment
No. 1 to Registration Statement on Form S-1
Cover
page
1. We
note your response to comment 2 and your disclosure that “[i]nvestors should also be
aware that Chinese regulatory authorities could disallow our corporate structure which would
likely result in a material change to our operations and/or decline in the value of the securities
registered under this offering.” Please further revise to state that the decline in
the value of the securities includes that it could become worthless.
Response:
We have updated the Registration Statement as requested.
2. You
disclose that SSHT exercises effective control over the operations of SJMC pursuant to a
series of contractual arrangements. We also note that you previously referred to SJMC as
“WFOE.” Please tell us whether you use a variable interest entity (VIE) structure.
If you do not, please affirmatively disclose, if true, that you do not use a VIE structure.
Please also explain the significance of the contractual agreements and tell us what consideration
you gave to filing these agreements as exhibits to the registration statement.
Response:
SSHT owns 100% of WHL and WHL owns 100% of SJMC. SJMC is a Wholly Foreign Owned Enterprise (“WFOE”). SSHT controls the
operations of SJMC and is entitled to the economic benefits derived from SJMC operations. As such, there are no contractual agreements
between SSHT, WHL, of SJMC and references to any contractual agreements between these entities have been removed from the Registration
Statement. The Company does not employ a VIE structure and we have affirmatively disclosed this fact as requested.
3. We
note your response to comment 3. Please revise to make clear that these risks could result
in a material change in your operations. Make conforming changes throughout the document.
Response:
We have updated the Registration Statement as requested.
4. We
note your statement that the Cyberspace Administration of China “launched an investigation
which recently culminated in an announcement favouring plans to delist in the US in favour
of Hong Kong.” This description does not appear to explain the recent actions of the
CAC. Please revise to explain the recent actions taken by the CAC, including the Measures
for Cybersecurity Review and the Draft Regulations on Network Data Security. Make similar
changes elsewhere that you discuss the CAC.
Response:
We have updated the Registration Statement as requested.
5. We
note your response to comment 4 and reissue in part. Please revise the prospectus, as you
do in your correspondence, to clearly disclose how you will refer to the holding company
and each subsidiary, including SJMC and WHL throughout the document so that it is clear to
investors which entity the disclosure is referencing.
Response:
We have updated the Registration Statement as requested.
6. We
note your response to comment 5 and reissue in part. Please revise to provide cross references
to the consolidated financial statements and to your discussion about how cash is transferred
in your summary, summary risk factors, and risk factors sections, as provided in the comment.
Response:
We have updated the Registration Statement as requested.
7. We
reissue comment 6. Please amend your disclosure here and in the risk factors sections to
state that, to the extent cash or assets in the business are in the PRC or a PRC entity,
the funds may not be available to fund operations or for other use outside of the PRC due
to interventions in or the imposition of restrictions and limitations on the ability of you
or your subsidiaries by the PRC government to transfer cash or assets. On the cover page,
provide cross-references to these other discussions.
Response:
We have updated the Registration Statement as requested.
8. Please
revise the cross references on the cover page to identify the specific risk factor instead
of using a general cross-reference to “Risks Related to Doing Business in China.”
Response:
We have updated the Registration Statement as requested.
9. Please
disclose which entity you are referring to when you use the term “Material PRC Company.”
Response:
We have updated the Registration Statement to replace all references to the term “Material PRC Company” with “SJMC”.
2
Our
Corporate History and Background, page 1
10. We
note your response to comment 14. Please revise to include a diagram to accompany your summary
of the company’s corporate structure on page 2. Identify clearly the entity in which
investors are purchasing their interest and the entity(ies) in which the company’s
operations are conducted. Further revise to describe the relevant contractual agreements
among you, WHL and/or SJMC that affect the manner in which you operate, impact your economic
rights, or impact your ability to control your subsidiaries. Disclose the uncertainties regarding
the challenges the company may face enforcing these contractual agreements due to legal uncertainties
and jurisdictional limits.
Response:
We have updated the Registration Statement as requested. there are no contractual agreements between SSHT, WHL, of SJMC and references
to any contractual agreements between these entities have been removed from the Registration Statement.
Prospectus
Summary, page 1
11. We
note your response to comment 8. We also note your disclosure on page 2 that “[t]he
Company faces many risk factors by having its operations in China,” and the risk involving
actions by the Chinese government to exert more oversight and control. Please revise to include
a separate section here that is titled “Summary of Risk Factors,” and separately
list each of the risks that your corporate structure and being based in or having the majority
of the company’s operations in China poses to investors, with cross- references to
each relevant individual detailed risk factor in the risk factor section. In the Summary
of Risk Factors, describe the significant regulatory, liquidity, and enforcement risks with
cross-references to the more detailed discussion of these risks in the prospectus. For example,
specifically discuss risks arising from the legal system in China, including risks and uncertainties
regarding the enforcement of laws and that rules and regulations in China can change quickly
with little advance notice; and the risk that the Chinese government may intervene or influence
your operations at any time, or may exert more control over offerings conducted overseas
and/or foreign investment in China-based issuers, which could result in a material change
in your operations and/or the value of the securities you are registering for sale. Acknowledge
any risks that any actions by the Chinese government to exert more oversight and control
over offerings that are conducted overseas and/or foreign investment in China-based issuers
could significantly limit or completely hinder your ability to offer or continue to offer
securities to investors and cause the value of such securities to significantly decline or
be worthless. We note that you discuss some of these risks in the narrative disclosure on
page 2, but these risks should be listed and discussed separately under the “Summary
of Risk Factors” heading.
Response:
We have updated the Registration Statement as requested.
12. We
note your response to comment 9 and reissue in part, to also disclose in this section your
current cash on hand, related-party loan and total current liabilities.
Response:
We have updated the Registration Statement as requested.
3
13. We
note your response to comment 10 and reissue to disclose each permission or approval that
you or your subsidiaries are required to obtain from Chinese authorities to operate your
business and to offer the securities being registered to foreign investors. Please revise
to clearly state whether or not you or your subsidiaries are covered by permissions requirements
from the China Securities Regulatory Commission (CSRC), Cyberspace Administration of China
(CAC) or any other governmental agency. To the extent that you believe certain permissions
or approvals are not required, discuss how you came to the conclusion, why that is the case,
and the basis on which you made that determination. If you relied on an opinion of counsel,
name counsel in the disclosure and file a consent of counsel as an exhibit. State affirmatively
whether you have received all requisite permissions or approvals and whether any permissions
or approvals have been denied. Please also describe the consequences to you and your investors
if you or your subsidiaries: (i) do not receive or maintain such permissions or approvals,
(ii) inadvertently conclude that such permissions or approvals are not required, or (iii)
applicable laws, regulations, or interpretations change and you are required to obtain such
permissions or approvals in the future. We note your statement that assuming no offer, issuance
or sale of common shares has been or will be made within the PRC, prior approval from the
CSRC is not required for the offering. Please explain your basis for this statement, as it
does not appear to correctly describe the application of CSRC regulations to overseas offerings.
Response:
We have updated the Registration Statement as requested.
14. We
note your response to comment 11. Please revise your disclosure to address the Trial Administrative
Measures of Overseas Securities Offering and Listing by Domestic Companies (the “Trial
Measures”), published by the China Securities Regulatory Commission on February 17,
2023. Describe the potential impact to you or your subsidiaries stemming from the Trial Measures,
if any.
Response:
We have updated the Registration Statement as requested.
15. We
note your response to comment 12 about how cash is transferred through the organization and
reissue in part. Please revise to provide cross-references to the consolidated financial
statements.
Response:
We have updated the Registration Statement as requested.
Business
Overview, page 3
16. You
disclose that the company “faces uncertainties as to whether market clearance is required,
and, if required, whether it can timely obtain such clearance, or at all,” and if you
are not able to obtain such clearance when required, your structure may be regarded as invalid
or illegal, which could result in you being unable to consolidate the financial results of
SJMC. Please revise your disclosure to clearly state which market clearance you are referencing,
and how such clearance could impact the ability to consolidate the financial results of SJMC.
Response:
We have updated the Registration Statement as requested.
4
Changes
in the U.S. capital markets..., page 8
17. Please
revise your risk factor to indicate that to date you have only had one client quoted on the